Openbookopenbook
Equity
BIOG
+0.0 · +0.00%
GBX · LSE

The Biotech Growth Trust PLC(BIOG) Stock Analysis | Financial Services

GBX --+0.00%
Reward69High
Risk37Moderate
75%Data
Strong 96% profit margin · Revenue growing 585% YoY
Quality Compounder
Market Cap:329.97M
ⓘ
Reward Rating
69
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
37
Moderate
Risk Assessment
7 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BIOG to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for BIOG, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is The Biotech Growth Trust PLC?

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP.

BIOG · Verdict

Solid reward · moderate risk

BIOG stands out on volatility and growth, but watch the balance sheet signal.

Based on 88% data coverage

BIOG · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Growth87/100

    Top decile vs peers

  • Profitability79/100

    98% net margin · 52% ROE

Watchouts 3

  • Balance sheet37/100

    Net debt/EBITDA 0.1×

  • Cash flow37/100

    -5% free-cash-flow margin

  • Valuation42/100

    Below average

Model-based scoring. For information only — not financial advice.

What is The Biotech Growth Trust PLC?

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The company is listed on the LSE in UK, operating in the Financial Services sector, with a market capitalisation of 329.97M, and a P/E ratio of 3.1x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (69)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Asset Management names that are close enough in size to make side-by-side comparison useful.

OITMicro Cap / 331M market cap
Odyssean Investment Trust PLC
Compare
CTUKMicro Cap / 333M market cap
CT UK Capital And Income Investment Trust Plc
Compare
BGSMicro Cap / 337M market cap
Baillie Gifford Shin Nippon PLC
Compare
Company Information
SectorFinancial Services
IndustryAsset Management
Market Cap329.97M
P/E Ratio3.1147
Dividend YieldN/A
Beta0.287
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.